INMED PHARMACEUTICALS INC. Public Float
INMED PHARMACEUTICALS INC. (INM) had Public Float of $2.97 million as of 2025-12-31, per its 10-K filed 2026-09-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-09-09
- 2025-12-31: Entity Public Float $2.97M.
- 2024-12-31: Entity Public Float $3.32M.
- 2023-12-31: Entity Public Float $2.35M.
- 2022-12-31: Entity Public Float $3.18M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-12-31 | $2.97M 10-K · filed 2026-09-09 | |
| 2024-12-31 | $3.32M 10-K/A · filed 2025-10-24 | |
| 2023-12-31 | $2.35M 10-K · filed 2024-09-30 | |
| 2022-12-31 | $3.18M 10-K/A · filed 2023-12-21 | |
| 2021-12-31 | $18.04M 10-K/A · filed 2022-09-28 | $0.00 10-K · filed 2022-09-23 |
| 2020-12-31 | $0.00 10-K · filed 2021-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |